HOTCHKIS & WILEY's ANIP Position Overview
HOTCHKIS & WILEY (via Hotchkis & Wiley Capital Management LLC) currently holds 74,460 shares of ANI Pharmaceuticals, Inc. (ANIP) worth $6.82 M, representing 0.02% of the portfolio. First purchased in 2024-Q3, this short-term holding has been held for 5 quarters.
Based on 13F filings, HOTCHKIS & WILEY has maintained this position in ANIP for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2025, adding 51,420 shares. Largest reduction occurred in Q2 2025, reducing 21,990 shares.
Analysis based on 13F filings available since 2013 Q2
HOTCHKIS & WILEY's ANI Pharmaceuticals (ANIP) Holding Value Over Time
Track share changes against reported price movement
Quarterly ANI Pharmaceuticals (ANIP) Trades by HOTCHKIS & WILEY
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2024 | +52,080 | New Buy | 52,080 | $59.66 |
| Q4 2024 | +5,100 | Add 9.79% | 57,180 | $55.28 |
| Q1 2025 | +51,420 | Add 89.93% | 108,600 | $66.95 |
| Q2 2025 | -21,990 | Reduce 20.25% | 86,610 | $65.25 |
| Q3 2025 | -12,150 | Reduce 14.03% | 74,460 | $91.60 |
HOTCHKIS & WILEY's ANI Pharmaceuticals Investment FAQs
HOTCHKIS & WILEY first purchased ANI Pharmaceuticals, Inc. (ANIP) in Q3 2024, acquiring 52,080 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
HOTCHKIS & WILEY has held ANI Pharmaceuticals, Inc. (ANIP) for 5 quarters since Q3 2024. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
HOTCHKIS & WILEY's largest addition to ANI Pharmaceuticals, Inc. (ANIP) was in Q3 2024, adding 52,080 shares worth $3.11 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, HOTCHKIS & WILEY's firm, Hotchkis & Wiley Capital Management LLC, owns 74,460 shares of ANI Pharmaceuticals, Inc. (ANIP), valued at approximately $6.82 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, ANI Pharmaceuticals, Inc. (ANIP) represents approximately 0.02% of HOTCHKIS & WILEY's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
HOTCHKIS & WILEY's peak holding in ANI Pharmaceuticals, Inc. (ANIP) was 108,600 shares, as reported at the end of Q1 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.